Pancreatic Intraepithelial Neoplasia

Pancreas

Volumn 28, Issue 3, 2004, Pages 257-262

  Takaori, Kyoichi ^a   Hruban, Ralph H ^b   Maitra, Anirban ^b   Tanigawa, Nobuhiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Carcinoma in situ; Intraductal papillary mucinous neoplasm; Intraductal papillary mucinous tumor; Pancreatic intraepithelial neoplasia

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER INVASION; CARCINOMA IN SITU; EPITHELIUM TUMOR; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; JAPAN; PANCREAS CANCER; PANCREAS DUCT; PANCREAS TUMOR; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; UNITED STATES;

ADENOCARCINOMA, MUCINOUS; ADENOMA; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; HUMANS; INTERNATIONAL COOPERATION; MODELS, GENETIC; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; TERMINOLOGY;

EID: 1842483164     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200404000-00008     Document Type: Review

References (56)

1. Lin Y, Tamakoshi A, Wakai K, et al. Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol. 1998;8:52-59.
2. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
3. Satake K, Saitoh Y, Takayama Y. Pancreatic surgery in Japan: historical review. Pancreas. 1998;16:223-226.
4. Matsuno S, Egawa S, Arai K. Trends in treatment for pancreatic cancer. J Hepatobiliary Pancreat Surg. 2001;8:544-548.
5. Takada T. Surgery for carcinoma of the pancreas in Japan. Past, present, and future aspects. Digestion. 1999;60(suppl 1):114-119.
6. Isozaki H, Okajima K, Morita S, et al. Review of pancreatic cancer. Bull Osaka Med Coll. 1990;36:1-11.
7. Tanaka S, Nakaizumi A, Ioka T, et al. Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer. Jpn J Clin Oncol. 2002;32:407-411.
8. Ishikawa O, Ohigashi H, Imaoka S, et al. Minute carcinoma of the pancreas measuring 1 cm or less in diameter - collective review of Japanese case reports. Hepatogastroenterology. 1999;46:8-15.
9. Tsuchiya R, Tajima Y, Matsuzaki S, et al. Early pancreatic cancer. Pancreatology. 2001;1:597-603.
10. Fujikawa T, Matsusue S, Nakamura Y, et al. Role of magnetic resonance cholangiopancreatography in diagnosing pancreatic cancer originating from the peripheral duct. Am J Gastroenterol. 2000;95:1378-1379.
11. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
12. Hulst SPL. Zur kenntnis der Genese des Adenokarzinoms und Karzinoms des Pankreas. Virchows Arch. 1905;180:288-316.
13. Sommers SC, Murphy SA, Warren S. Pancreatic duct hyperplasia and cancer. Gastroenterology. 1954;27:629-640.
14. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res. 1976;36: 2690-2698.
15. Kozuka S, Sassa R, Taki T, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer. 1979;43:1418-1428.
16. Klimstra DS, Longnecker DS. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol. 1994;145:1547-1550.
17. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579-586.
18. Takaori K. Carcinoma in situ of the pancreas [in Japanese with an English abstract]. Suizou. 2000;15:426-438.
19. Wilentz RE, Iacobuzio-Donahue CA, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 2000;60:2002-2006.
20. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 1997;57:2140-2143.
21. Lüttges J, Galehdari H, Brocker V, et al. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol. 2001;158:1677-1683.
22. Fukushima N, Sato N, Ueki T, et al. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol. 2002;160:1573-1581.
23. Biankin AV, Kench JG, Morey AL, et al. Overexpression of p21(WAF1/CiP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res. 2001;61:8830-8837.
24. Goggins M, Hruban RH, Kern SE, et al. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol. 2000;156:1767-1771.
25. Maitra A, Adsay NV, Argani P, et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol. 2003;16:902-912.
26. Hruban RH, Goggins M, Parsons JL, et al. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6:2969-2972.
27. Takaori K, Matsusue S, Fujikawa T, et al. Carcinoma in situ of the pancreas associated with localized fibrosis: a clue to early detection of neoplastic lesions arising from pancreatic ducts. Pancreas. 1998;17:102-105.
28. Takaori K, Kobashi Y, Matsusue S, et al. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. J Hepatobiliary Pancreat Surg. 2003;10: 125-136.
29. Yamaguchi K, Nakamura K, Yokohata K, et al. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Report of two cases. Int J Pancreatol. 1997;22:227-231.
30. Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484-490.
31. Kogire M, Tokuhara K, Itoh D, et al. Atypical ductal hyperplasia of the pancreas associated with a stricture of the main pancreatic duct. J Gastroenterol. 2003;38:295-297.
32. Takaori K. Dilemma in classifications of possible precursors of pancreatic cancer involving the main pancreatic duct: PanIN or IPMN? J Gastroenterol. 2003;38:311-313.
33. Brat DJ, Lillemoe KD, Yeo CJ, et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol. 1998;22:163-169.
34. Brockie E, Anand A, Albores-Saavedra J. Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol. 1998;2:286-292.
35. Ohhashi K, Murakami Y, Takekoshi T. Four cases of "mucin producing" cancer of the pancreas on specific findings of the papilla of Vater [in Japanese with an English abstract]. Prog Diagn Endosc. 1982;20:348-351.
36. Kimura W, Sasahira N, Yoshikawa T, et al. Duct-ectatic type of mucin producing tumor of the pancreas - new concept of pancreatic neoplasia. Hepatogastroenterology. 1996;43:692-709.
37. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425:357-367.
38. Longnecker DS, Adler G, Hruban RH, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000:237-240.
39. Solcia E, Capella C, Klöppel G. Atlas of tumor pathology: tumors of the pancreas. Washington, DC: Armed Forces Institute of Pathology, 1997.
40. Klöppel G. Pathology of nonendocrine pancreatic tumors. In: Go VLW, DiMagno EP, Gardner JD, et al., eds. The pancreas, 2nd ed. New York: Raven Press; 1993:871-897.
41. Mizumoto K, Inagaki T, Koizumi M, et al: Early pancreatic duct adenocarcinoma. Hum Pathol. 1988;19:242-244.
42. Obara T, Saitoh Y, Maguchi H, et al. Multicentric development of pancreatic intraductal carcinoma through atypical papillary hyperplasia. Hum Pathol. 1992;23:82-85.
43. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131-1136.
44. Fukushima N, Mukai K, Kanai Y, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol. 1997;28:1010-1017.
45. Adsay NV, Conlon KC, Zee SY, et al. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002;94:62-77.
46. Soldini D, Gugger M, Burckhardt E, et al. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts. J Pathol. 2003;199:453-461.
47. Seidel G, Zahurak M, Iacobuzio-Donahue CA, et al. Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases. Am J Surg Pathol. 2002;26:56-63.
48. Yanagisawa A, Kato Y, Ohtake K, et al. c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res. 1991;82:1057-1060.
49. Sasaki S, Yamamoto H, Kaneto H, et al. Differential roles of alterations of p53, p 16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep. 2003;10:21-25.
50. Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 2002;9:76-85.
51. Kawahira H, Kobayashi S, Kaneko K, et al. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. Hepatogastroenterology. 2000;47:973-977.
52. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. DPC-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal carcinomas. Am J Pathol. 2000;24:1544-1548.
53. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-1095.
54. Yonezawa S, Taira M, Osako M, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int. 1998;48:319-322.
55. Nakamura A, Horinouchi M, Goto M, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol. 2002;197:201-210.
56. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasms (IPMNs). Am J Surg Pathol. (in press).